CCCC 8-K: SEC filing
Filed with the SEC on · accession 0001628280-26-070560
CCCC filed a 8-K (current report) with the SEC on Nov 5, 2026. C4 Therapeutics furnished a press release announcing its financial results and business highlights for the quarter ended September 30, 2026. The stock moved -5.4% by the first close after the filing.
Summary of the filing
C4 Therapeutics furnished a press release announcing its financial results and business highlights for the quarter ended September 30, 2026. The filing is an earnings release under Item 2.02 of Form 8-K.
Key details
How CCCC stock reacted
Close before
$3.12
Nov 4, 2026
First close after
-5.45%
$2.95
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for CCCC, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for CCCC?
Click hereFrequently asked questions
What did CCCC file with the SEC on Nov 5, 2026?
CCCC filed a 8-K (SEC filing). C4 Therapeutics furnished a press release announcing its financial results and business highlights for the quarter ended September 30, 2026. The filing is an earnings release under Item 2.02 of Form 8-K.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
How did CCCC stock react to this filing?
CCCC closed at $3.12 before the filing and $2.95 on Nov 5, 2026 (-5.45%).
Other CCCC SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · Fda approvalSep 25, 2026
- 8-K · SEC filingAug 11, 2026
- 10-Q · SEC filingAug 11, 2026
- 8-K · SEC filingJun 24, 2026
- 8-K · Fda approvalJun 11, 2026
- 144 · Insider sale plannedMay 28, 2026
- 8-K · Executive departureMay 15, 2026
- 8-K · SEC filingMay 12, 2026
- 10-Q · SEC filingMay 12, 2026
Get alerts when CCCC files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days